Bayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit Post author:Sam Post published:November 29, 2017 Post category:BioPharma The company’s head of Development, Joerg Moeller, is taking the reins of the company’s new R&D program. Source: BioSpace You Might Also Like AmerisourceBergen Coughs Up $625M to Resolve U.S. Government Probe November 21, 2017 <b>BioPharm Executive:</b> What Could Trump's Meltdown Mean for Biotech? August 29, 2017 Gene Therapy Firm Files for $35 Million IPO August 21, 2017